Shirahase H[au] - Search Results

Year	Number of Results
1979	1
1982	2
1987	3
1988	4
1989	2
1990	4
1991	5
1992	1
1993	4
1994	5
1995	5
1996	2
1997	2
1998	3
1999	3
2000	6
2001	4
2003	2
2004	2
2006	2
2007	1
2008	6
2009	2
2010	3
2011	5
2012	3
2014	2
2015	1
2017	2
2018	2
2019	2
2020	1
2021	4
2022	0

1

CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.

Fukasawa K, Kadota T, Horie T, Tokumura K, Terada R, Kitaguchi Y, Park G, Ochiai S, Iwahashi S, Okayama Y, Hiraiwa M, Yamada T, Iezaki T, Kaneda K, Yamamoto M, Kitao T, Shirahase H, Hazawa M, Wong RW, Todo T, Hirao A, Hinoi E. Fukasawa K, et al. Among authors: shirahase h. Oncogene. 2021 Apr;40(15):2803-2815. doi: 10.1038/s41388-021-01745-1. Epub 2021 Mar 16. Oncogene. 2021. PMID: 33727660

2

[A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation].

Kitao T, Ito Y, Fukui M, Yamamoto M, Shoji Y, Takeda S, Shirahase H. Kitao T, et al. Among authors: shirahase h. Yakugaku Zasshi. 2019;139(1):19-25. doi: 10.1248/yakushi.18-00154-2. Yakugaku Zasshi. 2019. PMID: 30606923 Free article. Review. Japanese.

3

2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.

Morishita K, Shoji Y, Fukui M, Ito Y, Kitao T, Ozawa SI, Hirono S, Shirahase H. Morishita K, et al. Among authors: shirahase h. Chem Pharm Bull (Tokyo). 2018;66(12):1131-1152. doi: 10.1248/cpb.c18-00571. Chem Pharm Bull (Tokyo). 2018. PMID: 30504630 Free article.

4

Thyroid metastasis of pulmonary adenocarcinoma with EGFR G719A mutation: Genetic confirmation with liquid-based cytology specimens.

Yamada Y, Shirahase H, Fukiya M, Yoshizawa A, Minamiguchi S, Ozasa H, Haga H. Yamada Y, et al. Among authors: shirahase h. Cytopathology. 2021 May;32(3):364-366. doi: 10.1111/cyt.12940. Epub 2020 Dec 22. Cytopathology. 2021. PMID: 33184941 No abstract available.

5

Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor γ Modulator, in Male Diabetic Mice and Female Ovariectomized Rats.

Ito Y, Yamamoto M, Furukawa S, Fukui M, Morishita K, Kitao T, Shirahase H. Ito Y, et al. Among authors: shirahase h. Biol Pharm Bull. 2021;44(5):659-668. doi: 10.1248/bpb.b20-01002. Biol Pharm Bull. 2021. PMID: 33952822 Free article.

6

Synthesis and Evaluation of a Novel Series of 2,7-Substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Selective Peroxisome Proliferator-Activated Receptor γ Partial Agonists.

Morishita K, Ito Y, Otake K, Takahashi K, Yamamoto M, Kitao T, Ozawa SI, Hirono S, Shirahase H. Morishita K, et al. Among authors: shirahase h. Chem Pharm Bull (Tokyo). 2021;69(4):333-351. doi: 10.1248/cpb.c20-00841. Chem Pharm Bull (Tokyo). 2021. PMID: 33790079 Free article.

7

Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive Actions.

Morishita K, Shoji Y, Tanaka S, Fukui M, Ito Y, Kitao T, Ozawa SI, Hirono S, Shirahase H. Morishita K, et al. Among authors: shirahase h. Chem Pharm Bull (Tokyo). 2017;65(12):1144-1160. doi: 10.1248/cpb.c17-00635. Chem Pharm Bull (Tokyo). 2017. PMID: 29199219 Free article.

8

(S)-1,2,3,4-Tetrahydroisoquinoline Derivatives Substituted with an Acidic Group at the 6-Position as a Selective Peroxisome Proliferator-Activated Receptor γ Partial Agonist.

Morishita K, Miike T, Takeda S, Fukui M, Ito Y, Kitao T, Ozawa SI, Hirono S, Shirahase H. Morishita K, et al. Among authors: shirahase h. Chem Pharm Bull (Tokyo). 2019;67(11):1211-1224. doi: 10.1248/cpb.c19-00541. Chem Pharm Bull (Tokyo). 2019. PMID: 31685749 Free article.

9

Modified rapid urease test for Helicobacter pylori detection in relation to an immunohistochemical stain.

Tokunaga Y, Shirahase H, Yamamoto E, Inao R, Hamaguchi S, Kanaji K, Kitaoka A, Yagi T, Tokuka A, Ohsumi K. Tokunaga Y, et al. Among authors: shirahase h. J Gastroenterol Hepatol. 2000 Jun;15(6):617-21. doi: 10.1046/j.1440-1746.2000.02213.x. J Gastroenterol Hepatol. 2000. PMID: 10921414

10

Density of Helicobacter pylori infection evaluated semiquantitatively in gastric cancer.

Tokunaga Y, Shirahase H, Hoppou T, Kitaoka A, Tokuka A, Ohsumi K. Tokunaga Y, et al. Among authors: shirahase h. J Clin Gastroenterol. 2000 Oct;31(3):217-21. doi: 10.1097/00004836-200010000-00006. J Clin Gastroenterol. 2000. PMID: 11034000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results